LAUREN SHEPHERD: Open Payments
NPI 1013629864 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 39 payments from 15 companies in 2025. Trend: 2023 $1,457 · 2024 $788 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
| ABBVIE INC. | 6 | $126 |
| Braintree Laboratories, Inc. | 3 | $119 |
| Janssen Scientific Affairs, LLC | 1 | $80 |
| Janssen Biotech, Inc. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Ardelyx, Inc. | 2 | $34 |
Products named: TREMFYA, VOQUEZNA, SUFLAVE, RINVOQ, XIFAXAN, IQIRVO, ENTYVIO, GATTEX.
Industry payments across TX — which companies pay providers there.
